Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Equipment

ULGX:US

0.1300 USD 0.0100 7.14%

As of 13:07:41 ET on 04/27/2015.

Snapshot for Urologix Inc (ULGX)

Open: 0.1300 Day's Range: 0.0704 - 0.1300 Volume: 8,255
Previous Close: 0.1400 52wk Range: 0.0401 - 0.2039 1-Yr Rtn: -18.75%

Stock Chart for ULGX

No chart data available.
  • ULGX:US 0.1300
  • 1D
  • 1M
  • 1Y
0.1400
Interactive ULGX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ULGX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.2000
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 2.84
Shares Outstanding (M) 21.86
30 Day Average Volume 10,010
Price/Book (mrq) -
Price/Sale (ttm) 0.2189
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ULGX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ULGX

Urologix, Inc. develops, manufactures, and markets minimally invasive medical products for the treatment of urological disorders. The Company's Targis System is a non-surgical, anesthesia-free, catheter-based therapy that uses a proprietary microwave technology for the treatment of benign prostatic hyperplasia.

Gregory J Fluet "Greg"Chief Executive OfficerScott M MadsonChief Financial Officer
Lisa AckermanExec VP:Sales & Marketing
More Company Profile & Key Executives for ULGX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil